Negative regulation of CARD11 signaling and lymphoma cell survival by the E3 ubiquitin ligase RNF181

Sarah M. Pedersen, Waipan Chan, Rakhi P. Jattani, deMauri S. Mackie, Joel L. Pomerantz

Research output: Research - peer-reviewArticle

Abstract

NF-κB activation downstream of antigen receptor engagement is a highly regulated event required for lymphocyte activation during the adaptive immune response. The pathway is often dysregulated in lymphoma, leading to constitutive NF-κB activity that supports the aberrant proliferation of transformed lymphocytes. To identify novel regulators of antigen receptor signaling to NF-κB, we developed bioluminescence resonance energy transfer-based interaction cloning (BRIC), a screening strategy that can detect protein-protein interactions in live mammalian cells in a high-throughput manner. Using this strategy, we identified the RING finger protein RNF181 as an interactor of CARD11, a key signaling scaffold in the antigen receptor pathway. We present evidence that RNF181 functions as an E3 ubiquitin ligase to inhibit antigen receptor signaling to NF-κB downstream of CARD11. The levels of the obligate signaling protein Bcl10 are reduced by RNF181 even prior to signaling, and Bcl10 can serve as a substrate for RNF181 E3 ligase activity in vitro. Furthermore, RNF181 limits the proliferation of human diffuse large B cell lymphoma cells that depend upon aberrant CARD11 signaling to NF-κB for growth and survival in culture. Our results define a new regulatory checkpoint that can modulate the output of CARD11 signaling to NF-κB in both normal and transformed lymphocytes.

LanguageEnglish (US)
Pages794-808
Number of pages15
JournalMolecular and Cellular Biology
Volume36
Issue number5
DOIs
StatePublished - 2016

Fingerprint

Antigen Receptors
Ubiquitin-Protein Ligases
Lymphoma
Cell Survival
Proteins
Lymphocytes
Lymphoma, Large B-Cell, Diffuse
Energy Transfer
Adaptive Immunity
Lymphocyte Activation
Organism Cloning
Survival
Growth
In Vitro Techniques

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Negative regulation of CARD11 signaling and lymphoma cell survival by the E3 ubiquitin ligase RNF181. / Pedersen, Sarah M.; Chan, Waipan; Jattani, Rakhi P.; Mackie, deMauri S.; Pomerantz, Joel L.

In: Molecular and Cellular Biology, Vol. 36, No. 5, 2016, p. 794-808.

Research output: Research - peer-reviewArticle

Pedersen, Sarah M. ; Chan, Waipan ; Jattani, Rakhi P. ; Mackie, deMauri S. ; Pomerantz, Joel L./ Negative regulation of CARD11 signaling and lymphoma cell survival by the E3 ubiquitin ligase RNF181. In: Molecular and Cellular Biology. 2016 ; Vol. 36, No. 5. pp. 794-808
@article{ee7538dd741944748c7d53e1f56f41f7,
title = "Negative regulation of CARD11 signaling and lymphoma cell survival by the E3 ubiquitin ligase RNF181",
abstract = "NF-κB activation downstream of antigen receptor engagement is a highly regulated event required for lymphocyte activation during the adaptive immune response. The pathway is often dysregulated in lymphoma, leading to constitutive NF-κB activity that supports the aberrant proliferation of transformed lymphocytes. To identify novel regulators of antigen receptor signaling to NF-κB, we developed bioluminescence resonance energy transfer-based interaction cloning (BRIC), a screening strategy that can detect protein-protein interactions in live mammalian cells in a high-throughput manner. Using this strategy, we identified the RING finger protein RNF181 as an interactor of CARD11, a key signaling scaffold in the antigen receptor pathway. We present evidence that RNF181 functions as an E3 ubiquitin ligase to inhibit antigen receptor signaling to NF-κB downstream of CARD11. The levels of the obligate signaling protein Bcl10 are reduced by RNF181 even prior to signaling, and Bcl10 can serve as a substrate for RNF181 E3 ligase activity in vitro. Furthermore, RNF181 limits the proliferation of human diffuse large B cell lymphoma cells that depend upon aberrant CARD11 signaling to NF-κB for growth and survival in culture. Our results define a new regulatory checkpoint that can modulate the output of CARD11 signaling to NF-κB in both normal and transformed lymphocytes.",
author = "Pedersen, {Sarah M.} and Waipan Chan and Jattani, {Rakhi P.} and Mackie, {deMauri S.} and Pomerantz, {Joel L.}",
year = "2016",
doi = "10.1128/MCB.00876-15",
volume = "36",
pages = "794--808",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Negative regulation of CARD11 signaling and lymphoma cell survival by the E3 ubiquitin ligase RNF181

AU - Pedersen,Sarah M.

AU - Chan,Waipan

AU - Jattani,Rakhi P.

AU - Mackie,deMauri S.

AU - Pomerantz,Joel L.

PY - 2016

Y1 - 2016

N2 - NF-κB activation downstream of antigen receptor engagement is a highly regulated event required for lymphocyte activation during the adaptive immune response. The pathway is often dysregulated in lymphoma, leading to constitutive NF-κB activity that supports the aberrant proliferation of transformed lymphocytes. To identify novel regulators of antigen receptor signaling to NF-κB, we developed bioluminescence resonance energy transfer-based interaction cloning (BRIC), a screening strategy that can detect protein-protein interactions in live mammalian cells in a high-throughput manner. Using this strategy, we identified the RING finger protein RNF181 as an interactor of CARD11, a key signaling scaffold in the antigen receptor pathway. We present evidence that RNF181 functions as an E3 ubiquitin ligase to inhibit antigen receptor signaling to NF-κB downstream of CARD11. The levels of the obligate signaling protein Bcl10 are reduced by RNF181 even prior to signaling, and Bcl10 can serve as a substrate for RNF181 E3 ligase activity in vitro. Furthermore, RNF181 limits the proliferation of human diffuse large B cell lymphoma cells that depend upon aberrant CARD11 signaling to NF-κB for growth and survival in culture. Our results define a new regulatory checkpoint that can modulate the output of CARD11 signaling to NF-κB in both normal and transformed lymphocytes.

AB - NF-κB activation downstream of antigen receptor engagement is a highly regulated event required for lymphocyte activation during the adaptive immune response. The pathway is often dysregulated in lymphoma, leading to constitutive NF-κB activity that supports the aberrant proliferation of transformed lymphocytes. To identify novel regulators of antigen receptor signaling to NF-κB, we developed bioluminescence resonance energy transfer-based interaction cloning (BRIC), a screening strategy that can detect protein-protein interactions in live mammalian cells in a high-throughput manner. Using this strategy, we identified the RING finger protein RNF181 as an interactor of CARD11, a key signaling scaffold in the antigen receptor pathway. We present evidence that RNF181 functions as an E3 ubiquitin ligase to inhibit antigen receptor signaling to NF-κB downstream of CARD11. The levels of the obligate signaling protein Bcl10 are reduced by RNF181 even prior to signaling, and Bcl10 can serve as a substrate for RNF181 E3 ligase activity in vitro. Furthermore, RNF181 limits the proliferation of human diffuse large B cell lymphoma cells that depend upon aberrant CARD11 signaling to NF-κB for growth and survival in culture. Our results define a new regulatory checkpoint that can modulate the output of CARD11 signaling to NF-κB in both normal and transformed lymphocytes.

UR - http://www.scopus.com/inward/record.url?scp=84961198654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961198654&partnerID=8YFLogxK

U2 - 10.1128/MCB.00876-15

DO - 10.1128/MCB.00876-15

M3 - Article

VL - 36

SP - 794

EP - 808

JO - Molecular and Cellular Biology

T2 - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 5

ER -